Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Shintaro Hokaiwado"'
Autor:
Takeshi Fukuhara, Jia Kim, Shintaro Hokaiwado, Makiko Nawa, Hayato Okamoto, Tomohiko Kogiso, Tetsuro Watabe, Nobutaka Hattori
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0181502 (2017)
There are currently several antibody therapies that directly target tumors, and antibody-drug conjugates represent a novel moiety as next generation therapeutics. Here, we used a unique screening probe, DT3C, to identify functional antibodies that re
Externí odkaz:
https://doaj.org/article/b9c7099ed63744b5a5bd0a6843df65c8
Autor:
Toshio Kitamura, Jiro Kitaura, Akihiro Ito, Hirotaka Matsui, Hironori Harada, Ye Ding, Norio Komatsu, Naoko Kato, Sayuri Nishikawa, Yoshihiro Hayashi, Yuka Harada, Jun Imagawa, Naoki Shingai, Yuki Kagiyama, Atsushi Iwama, Issay Kitabayashi, Yuki Maemoto, Shintaro Hokaiwado
Publikováno v:
Blood advances. 3(7)
Chronic myelomonocytic leukemia (CMML) constitutes a hematopoietic stem cell (HSC) disorder characterized by prominent monocytosis and myelodysplasia. Although genome sequencing has revealed the CMML mutation profile, the mechanism of disease develop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a047ce44755323038616a22f1ecb786a
https://pubmed.ncbi.nlm.nih.gov/30944097
https://pubmed.ncbi.nlm.nih.gov/30944097
Autor:
Tomohiko Kogiso, Tetsuro Watabe, Makiko Nawa, Hayato Okamoto, Jia Kim, Nobutaka Hattori, Shintaro Hokaiwado, Takeshi Fukuhara
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0181502 (2017)
PLoS ONE
PLoS ONE
There are currently several antibody therapies that directly target tumors, and antibody-drug conjugates represent a novel moiety as next generation therapeutics. Here, we used a unique screening probe, DT3C, to identify functional antibodies that re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed7c56151ee2736251b4e685230e9786
https://doi.org/10.1371/journal.pone.0181502
https://doi.org/10.1371/journal.pone.0181502